Poxel S.A.
Poxel S.A. (PXXLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PXXLF · as of Jun 9, 2026
Key Statistics
Explore Poxel S.A. Data
pxxlf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
pxxlf competitorsPXXLF
AMHV
BNOEF
CRPOF
EIGRQ
LVCLYStock Performance
Full HistoryAbout Poxel S.A.
Poxel S.A. a biopharmaceutical firm in the clinical stage, is dedicated to creating innovative treatments for a range of metabolic disorders, including type 2 diabetes and various liver ailments. Its…
what is poxel s.a. · pxxlf stock overview · poxel s.a. company profile · who is poxel s.a. ceo · pxxlf OTC · poxel s.a. headquarters · poxel s.a. business segments
About Stock Overview & Key Data
Poxel S.A. (PXXLF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 6, 2017. As of the latest trading session, PXXLF stock price is $0.26, with a market capitalization of $15.9M. The stock has returned +4.00% over the past 12 months and +4.00% year-to-date.
In fiscal year 2024, Poxel S.A. reported revenue of $6.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Poxel S.A. (PXXLF) stock price is $0.26. The stock is traded on OTC under the ticker symbol PXXLF. The 52-week range is $0.25 – $0.70.